| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.3 |